The epidemiology of mumps in Italy

Anna Giammanco; null De Simone; null Caciagli; Paolo Bonanni; null Campa; null Passerini; null Cavallaro; null Marsella; null Ciamarra; null Tagliatatela; null Camper; null Genna; null Lolli; null Sforza; Pietro Crovari; null Casentino; null De Simone; null Piscione; null Simula; null Bassetti; null Grandesso; null Rizza; null Marchetti; null Martelli; null Caciagli; null Palladino; null Caciagli; Antonella Zizza; null Zizza; null Mucignat; Sara Boccalini; Luigi Clerico; Antonella De Donno; null Perani; null Zizza; Angela Bechini; null Tronci; Marta L. Ciofi Degli Atti; null Giammanco; Maria Cristina Rota; Giovanni Gabutti; null Icardi; Danilo Villalta; null Goglio; null Focà; Marcello Guido; null Giancotti; null Favero; null Caraccio; Anna Zizza

The epidemiology of mumps in Italy

Anna Giammanco, De Simone, Caciagli, Paolo Bonanni, Campa, Passerini, Cavallaro, Marsella, Ciamarra, Tagliatatela, Camper, Genna, Lolli, Sforza, Pietro Crovari, Casentino, De Simone, Piscione, Simula, BassettiGrandesso, Rizza, Marchetti, Martelli, Caciagli, Palladino, Caciagli, Antonella Zizza, Zizza, Mucignat, Sara Boccalini, Luigi Clerico, Antonella De Donno, Perani, Zizza, Angela Bechini, Tronci, Marta L. Ciofi Degli Atti, Giammanco, Maria Cristina Rota, Giovanni Gabutti, Icardi, Danilo Villalta, Goglio, Focà, Marcello Guido, Giancotti, Favero, Caraccio, Anna Zizza

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Article › peer review

10 Citazioni (Scopus)

Abstract

In Italy, although vaccination has been recommended for a number of years, vaccination coverage formumps is still sub-optimal. The objective of the present study was to evaluate the seroprevalence ofmumps antibodies in the Italian population, stratified by age, gender and geographical area. The proportionof individuals positive for mumps antibodies remained stable in the age classes 0–11 months and 1year (25.4% and 30.8%, respectively) and showed a continuous increase after the second year of life. Thepercentage of susceptible individuals was higher than 20% in persons 2–14 years of age and exceeded10% in persons 15–39 years of age. No statistically significant differences were observed by gender orgeographical area. Comparison between these results and the data obtained from a 1996 survey showeda statistically significant increase in seroprevalence in the age class 2–4 years. No changes were observedin the other age-groups. The results of this study confirm that the efforts made in recent years to improvevaccination coverage within the second year of life should be strengthened.

Lingua originale	English
pagine (da-a)	2906-2911
Numero di pagine	6
Rivista	Vaccine
Volume	26(23)
Stato di pubblicazione	Published - 2008

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.1300.1313???
???subjectarea.asjc.2400.2400???
???subjectarea.asjc.3400.3400???
???subjectarea.asjc.2700.2739???
???subjectarea.asjc.2700.2725???

Altri file e collegamenti

OA Link

Cita questo

Giammanco, A, De Simone, Caciagli, Bonanni, P, Campa, Passerini, Cavallaro, Marsella, Ciamarra, Tagliatatela, Camper, Genna, Lolli, Sforza, Crovari, P, Casentino, De Simone, Piscione, Simula, Bassetti, Grandesso, Rizza, Marchetti, Martelli, Caciagli, Palladino, Caciagli, Zizza, A, Zizza, Mucignat, Boccalini, S, Clerico, L, De Donno, A, Perani, Zizza, Bechini, A, Tronci, Ciofi Degli Atti, ML, Giammanco, Rota, MC, Gabutti, G, Icardi, Villalta, D, Goglio, Focà, Guido, M, Giancotti, Favero, Caraccio & Zizza, A 2008, 'The epidemiology of mumps in Italy', Vaccine, vol. 26(23), pagg. 2906-2911.

@article{b7e5aa5c99444cfab307bc5c827cf89a,

title = "The epidemiology of mumps in Italy",

abstract = "In Italy, although vaccination has been recommended for a number of years, vaccination coverage formumps is still sub-optimal. The objective of the present study was to evaluate the seroprevalence ofmumps antibodies in the Italian population, stratified by age, gender and geographical area. The proportionof individuals positive for mumps antibodies remained stable in the age classes 0–11 months and 1year (25.4% and 30.8%, respectively) and showed a continuous increase after the second year of life. Thepercentage of susceptible individuals was higher than 20% in persons 2–14 years of age and exceeded10% in persons 15–39 years of age. No statistically significant differences were observed by gender orgeographical area. Comparison between these results and the data obtained from a 1996 survey showeda statistically significant increase in seroprevalence in the age class 2–4 years. No changes were observedin the other age-groups. The results of this study confirm that the efforts made in recent years to improvevaccination coverage within the second year of life should be strengthened.",

keywords = "Mumps, Seroprevalence, Vaccination, Mumps, Seroprevalence, Vaccination",

author = "Anna Giammanco and {De Simone} and Caciagli and Paolo Bonanni and Campa and Passerini and Cavallaro and Marsella and Ciamarra and Tagliatatela and Camper and Genna and Lolli and Sforza and Pietro Crovari and Casentino and {De Simone} and Piscione and Simula and Bassetti and Grandesso and Rizza and Marchetti and Martelli and Caciagli and Palladino and Caciagli and Antonella Zizza and Zizza and Mucignat and Sara Boccalini and Luigi Clerico and {De Donno}, Antonella and Perani and Zizza and Angela Bechini and Tronci and {Ciofi Degli Atti}, {Marta L.} and Giammanco and Rota, {Maria Cristina} and Giovanni Gabutti and Icardi and Danilo Villalta and Goglio and Foc{\`a} and Marcello Guido and Giancotti and Favero and Caraccio and Anna Zizza",

year = "2008",

language = "English",

volume = "26(23)",

pages = "2906--2911",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - The epidemiology of mumps in Italy

AU - Giammanco, Anna

AU - De Simone, null

AU - Caciagli, null

AU - Bonanni, Paolo

AU - Campa, null

AU - Passerini, null

AU - Cavallaro, null

AU - Marsella, null

AU - Ciamarra, null

AU - Tagliatatela, null

AU - Camper, null

AU - Genna, null

AU - Lolli, null

AU - Sforza, null

AU - Crovari, Pietro

AU - Casentino, null

AU - De Simone, null

AU - Piscione, null

AU - Simula, null

AU - Bassetti, null

AU - Grandesso, null

AU - Rizza, null

AU - Marchetti, null

AU - Martelli, null

AU - Caciagli, null

AU - Palladino, null

AU - Caciagli, null

AU - Zizza, Antonella

AU - Zizza, null

AU - Mucignat, null

AU - Boccalini, Sara

AU - Clerico, Luigi

AU - De Donno, Antonella

AU - Perani, null

AU - Zizza, null

AU - Bechini, Angela

AU - Tronci, null

AU - Ciofi Degli Atti, Marta L.

AU - Giammanco, null

AU - Rota, Maria Cristina

AU - Gabutti, Giovanni

AU - Icardi, null

AU - Villalta, Danilo

AU - Goglio, null

AU - Focà, null

AU - Guido, Marcello

AU - Giancotti, null

AU - Favero, null

AU - Caraccio, null

AU - Zizza, Anna

PY - 2008

Y1 - 2008

N2 - In Italy, although vaccination has been recommended for a number of years, vaccination coverage formumps is still sub-optimal. The objective of the present study was to evaluate the seroprevalence ofmumps antibodies in the Italian population, stratified by age, gender and geographical area. The proportionof individuals positive for mumps antibodies remained stable in the age classes 0–11 months and 1year (25.4% and 30.8%, respectively) and showed a continuous increase after the second year of life. Thepercentage of susceptible individuals was higher than 20% in persons 2–14 years of age and exceeded10% in persons 15–39 years of age. No statistically significant differences were observed by gender orgeographical area. Comparison between these results and the data obtained from a 1996 survey showeda statistically significant increase in seroprevalence in the age class 2–4 years. No changes were observedin the other age-groups. The results of this study confirm that the efforts made in recent years to improvevaccination coverage within the second year of life should be strengthened.

AB - In Italy, although vaccination has been recommended for a number of years, vaccination coverage formumps is still sub-optimal. The objective of the present study was to evaluate the seroprevalence ofmumps antibodies in the Italian population, stratified by age, gender and geographical area. The proportionof individuals positive for mumps antibodies remained stable in the age classes 0–11 months and 1year (25.4% and 30.8%, respectively) and showed a continuous increase after the second year of life. Thepercentage of susceptible individuals was higher than 20% in persons 2–14 years of age and exceeded10% in persons 15–39 years of age. No statistically significant differences were observed by gender orgeographical area. Comparison between these results and the data obtained from a 1996 survey showeda statistically significant increase in seroprevalence in the age class 2–4 years. No changes were observedin the other age-groups. The results of this study confirm that the efforts made in recent years to improvevaccination coverage within the second year of life should be strengthened.

KW - Mumps

KW - Seroprevalence

KW - Vaccination

KW - Mumps

KW - Seroprevalence

KW - Vaccination

UR - http://hdl.handle.net/10447/49822

M3 - Article

VL - 26(23)

SP - 2906

EP - 2911

JO - Vaccine

JF - Vaccine

SN - 0264-410X

ER -

The epidemiology of mumps in Italy

Abstract

All Science Journal Classification (ASJC) codes

Altri file e collegamenti

Fingerprint

Cita questo